Skip to content

AQT90 FLEX D-dimer Clinical Sensitivity and Specificity

AQT90 FLEX D-dimer Clinical Sensitivity and Specificity

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06749223
Enrollment
600
Registered
2024-12-27
Start date
2022-04-04
Completion date
2025-06-30
Last updated
2025-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

VTE (Venous Thromboembolism)

Keywords

D-dimer

Brief summary

The goal of this study is evaluate the clinical performance of the AQT90 FLEX D-dimer Test as an aid in the diagnosis of Venous Thromboembolism.

Detailed description

The objective is to evaluate the clinical performance of the AQT90 FLEX D-dimer Test as an aid in the diagnosis of VTE in patients presenting with low or moderate pretest probability (PTP), by determining the clinical sensitivity, specificity, negative predictive value (NPV), positive predictive value (PPV), positive likelihood ratio (LR+) and negative likelihood ratio (LR-) of the assay.

Interventions

DIAGNOSTIC_TESTD-dimer test

Blood sample collection for D-dimer testing

Sponsors

Radiometer Medical ApS
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Subject is 18 years of age and older * Subject, who presents with signs and symptoms of VTE and had low or moderate pre-test probability of DVT or PE assessed by Well's score * Subject must be able to understand information given, and be willing and able to voluntarily give their consent to participate in this study

Exclusion criteria

* Subject, who is pregnant * Subject, who has received fibrinolytic therapy within the previous seven days * Subject, who has received treatment with anticoagulants (unfractionated heparin, LMWH, VKA (vitamin K-antagonists), DOACs (direct oral anticoagulants) within the previous seven days * Subject, who has had trauma or surgery within the previous four weeks * Subject with malignancy * Subject with disseminated intravascular coagulation (DIC) * Subject, who has an invalid written informed consent or has withdrawn consent

Design outcomes

Primary

MeasureTime frameDescription
Sensitivity and SpecificityFrom enrollment to blood sample collection; ~1 hourClinical performance (clinical sensitivity, clinical specificity, Negative Predictive Values (NPV), Positive Predictive Values (PPV), Positive Likelihood Ratio (LR+), Negative Likelihood Ratio (LR-) and 95 % confidence intervals) for the AQT90 FLEX D-dimer assay against the hospital diagnosis.

Countries

Denmark

Contacts

Primary ContactHelle Toftegaard Petersen
helle.toftegaard@radiometer.dk+45 29259390

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026